159 related articles for article (PubMed ID: 19794299)
1. Chromogranin A as a useful neuroendocrine marker in patients with autoimmune Addison's disease.
El Ali Z; Fichna M; Piniewska J; Kosowicz J; Grzymisławski M
J Endocrinol Invest; 2010 Mar; 33(3):186-91. PubMed ID: 19794299
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis.
Kalkan Ç; Karakaya F; Soykan İ
Turk J Gastroenterol; 2016 Nov; 27(6):515-520. PubMed ID: 27852542
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of gastrin levels for the diagnosis of gastric enterochromaffin-like cell hyperplasia in patients with Hashimoto's thyroiditis.
Nicolaou A; Thomas D; Alexandraki KI; Sougioultzis S; Tsolakis AV; Kaltsas G
Neuroendocrinology; 2014; 99(2):118-22. PubMed ID: 24776735
[TBL] [Abstract][Full Text] [Related]
4. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.
Sanduleanu S; De Bruïne A; Stridsberg M; Jonkers D; Biemond I; Hameeteman W; Lundqvist G; Stockbrügger RW
Eur J Clin Invest; 2001 Sep; 31(9):802-11. PubMed ID: 11589723
[TBL] [Abstract][Full Text] [Related]
5. [Influence of long-term gastric acid suppression therapy on the expression of serum gastrin, chromogranin A, and ghrelin].
Kim BW; Lee BI; Kim HK; Cho YS; Chae HS; Lee HK; Kim HJ; Han SW
Korean J Gastroenterol; 2009 Feb; 53(2):84-9. PubMed ID: 19237833
[TBL] [Abstract][Full Text] [Related]
6. Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin-like cell hyperplasia and autoimmune gastritis.
Herold Z; Herold M; Nagy P; Patocs A; Doleschall M; Somogyi A
J Diabetes Investig; 2020 Jul; 11(4):865-873. PubMed ID: 31883432
[TBL] [Abstract][Full Text] [Related]
7. A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.
Jianu CS; Fossmark R; Syversen U; Hauso Ø; Waldum HL
Tumour Biol; 2010 Oct; 31(5):373-80. PubMed ID: 20480408
[TBL] [Abstract][Full Text] [Related]
8. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
Hirschowitz BI; Worthington J; Mohnen J; Haber M
Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
[TBL] [Abstract][Full Text] [Related]
9. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids.
Peracchi M; Gebbia C; Basilisco G; Quatrini M; Tarantino C; Vescarelli C; Massironi S; Conte D
Eur J Endocrinol; 2005 Mar; 152(3):443-8. PubMed ID: 15757862
[TBL] [Abstract][Full Text] [Related]
10. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?
Alexandraki KI; Nikolaou A; Thomas D; Syriou V; Korkolopoulou P; Sougioultzis S; Kaltsas G
Clin Endocrinol (Oxf); 2014 May; 80(5):685-90. PubMed ID: 24118101
[TBL] [Abstract][Full Text] [Related]
11. [Study on histogenesis of enterochromaffin-like carcinoid in autoimmune atrophic gastritis associated with pernicious anemia].
Macukanović-Golubović L; Katić V; Rancić G; Milenović M; Marjanović G; Golubović Z
Vojnosanit Pregl; 2007 Aug; 64(8):543-8. PubMed ID: 17874722
[TBL] [Abstract][Full Text] [Related]
12. Polyautoimmunity in autoimmune gastritis.
Kalkan Ç; Soykan I
Eur J Intern Med; 2016 Jun; 31():79-83. PubMed ID: 27085391
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes.
De Block CE; Colpin G; Thielemans K; Coopmans W; Bogers JJ; Pelckmans PA; Van Marck EA; Van Hoof V; Martin M; De Leeuw IH; Bouillon R; Van Gaal LF
Diabetes Care; 2004 Jun; 27(6):1387-93. PubMed ID: 15161793
[TBL] [Abstract][Full Text] [Related]
14. The gastric mucosa 25 years after proximal gastric vagotomy.
Sagatun L; Jianu CS; Fossmark R; Mårvik R; Nordrum IS; Waldum HL
Scand J Gastroenterol; 2014 Oct; 49(10):1173-80. PubMed ID: 25157752
[TBL] [Abstract][Full Text] [Related]
15. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis.
Borch K; Stridsberg M; Burman P; Rehfeld JF
Scand J Gastroenterol; 1997 Mar; 32(3):198-202. PubMed ID: 9085454
[TBL] [Abstract][Full Text] [Related]
16. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study.
Sanduleanu S; Stridsberg M; Jonkers D; Hameeteman W; Biemond I; Lundqvist G; Lamers C; Stockbrügger RW
Aliment Pharmacol Ther; 1999 Feb; 13(2):145-53. PubMed ID: 10102943
[TBL] [Abstract][Full Text] [Related]
17. The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis.
Melcescu E; Hogan RB; Brown K; Boyd SA; Abell TL; Koch CA
Exp Mol Pathol; 2012 Dec; 93(3):434-40. PubMed ID: 23043903
[TBL] [Abstract][Full Text] [Related]
18. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Boyce M; Moore AR; Sagatun L; Parsons BN; Varro A; Campbell F; Fossmark R; Waldum HL; Pritchard DM
Br J Clin Pharmacol; 2017 Mar; 83(3):466-475. PubMed ID: 27704617
[TBL] [Abstract][Full Text] [Related]
19. Gastric carcinoid associated with achlorhydria, hypergastrinemia, and Addison's disease.
Bruce TA; Azmy M; Earll JM
South Med J; 1988 Dec; 81(12):1595-6. PubMed ID: 3059527
[TBL] [Abstract][Full Text] [Related]
20. Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor.
Kleveland O; Syversen U; Slørdahl K; Waldum HL
Digestion; 2001; 64(2):71-4. PubMed ID: 11684818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]